News & Updates

Show Multimedia Only

Aerobic exercise benefits individuals with cerebellar ataxia

19 Sep 2025 by

High-intensity aerobic training appears to be a better way to manage cerebellar ataxia than balance training, with favourable effects on symptoms, fatigue, and cardiorespiratory fitness seen in a randomized clinical trial.

Aerobic exercise benefits individuals with cerebellar ataxia

19 Sep 2025

Clinical research in non-university public hospitals correlated with improved patient outcomes

19 Sep 2025 by

More than 10 percent of full-time clinicians in Hong Kong’s non-university public hospitals engaged in original research as principal investigators (PIs), contributing to nearly one-third of the city’s peer-reviewed studies published in 2016–2021. Their clinical research activity is correlated with improved patient outcomes.

Clinical research in non-university public hospitals correlated with improved patient outcomes

19 Sep 2025

Vaginal estrogen tablets unlikely to increase risk of stroke recurrence

18 Sep 2025 by

Among women who have previously had an ischaemic stroke, the use of vaginal estradiol tablets does not raise the risk of having another stroke, according to new research.

Vaginal estrogen tablets unlikely to increase risk of stroke recurrence

18 Sep 2025

Behavioural therapy as good as medication for OAB symptoms in Parkinson’s disease

16 Sep 2025 by

In the treatment of overactive bladder (OAB) in patients with Parkinson’s disease, exercise-based behavioural therapy helps reduce symptoms and bother scores and improve quality of life, similar to what is achieved with drug therapy, as shown in a study.

Behavioural therapy as good as medication for OAB symptoms in Parkinson’s disease

16 Sep 2025

PM2.5 exposure factors in worsening dementia

16 Sep 2025

New research has linked exposure to fine particulate matter (PM2.5) to a worsening of dementia symptoms and an increase in the brain changes associated with Alzheimer’s disease.

PM2.5 exposure factors in worsening dementia

16 Sep 2025

GLP-1RAs look good for idiopathic intracranial hypertension

14 Sep 2025 by

Glucagon-like peptide 1 receptor agonists (GLP-1RAs) appear promising in the management of idiopathic intracranial hypertension, with a retrospective study showing that the drugs reduce symptom burden as well as the need for medications and invasive procedures.

GLP-1RAs look good for idiopathic intracranial hypertension

14 Sep 2025

Hydrogen–oxygen therapy alleviates sleep disorders and improves mood

12 Sep 2025 by

Inhalation of a low-dose mixture of hydrogen and oxygen effectively improves sleep quality and mood through its antioxidant properties, by reducing wake time, enhancing sleep quality and relieving psychological stress, a Chinese study has found.

Hydrogen–oxygen therapy alleviates sleep disorders and improves mood

12 Sep 2025

Increased risk of stroke in possible sarcopenia patients with fall history

12 Sep 2025 by

The risk of incident stroke in middle-aged and older patients with possible sarcopenia (PS) is higher in those with fall history than those without, according to the first study to establish fall history as a long-term stroke predictor in Asian PS cohorts.

Increased risk of stroke in possible sarcopenia patients with fall history

12 Sep 2025

Common blood test predicts which AD patients will have rapid cognitive decline

11 Sep 2025 by

Insulin resistance, detected through the routine triglyceride-glucose (TyG) index, identifies individuals with early Alzheimer’s disease (AD) who are four times more likely to experience rapid cognitive decline, findings from a new study presented at EAN 2025 suggest.

Common blood test predicts which AD patients will have rapid cognitive decline

11 Sep 2025

Neuropsychiatric AEs resolve after switch to doravirine-based ARV regimens

10 Sep 2025 by

Switching to a doravirine-based ARV regimen resolves neuropsychiatric AEs that were ongoing during a prior efavirenz-based regimen in DRIVE-AHEAD, with few events persisting 96 weeks after switching — a finding also seen in DRIVE-FORWARD, as shown in post hoc analyses of the OLEs of the two phase III trials

Neuropsychiatric AEs resolve after switch to doravirine-based ARV regimens

10 Sep 2025

News & Updates

Filter by Specialty:

Specialty:

Aerobic exercise benefits individuals with cerebellar ataxia

Aerobic exercise benefits individuals with cerebellar ataxia

Clinical research in non-university public hospitals correlated with improved patient outcomes

Clinical research in non-university public hospitals correlated with improved patient outcomes

Vaginal estrogen tablets unlikely to increase risk of stroke recurrence

Vaginal estrogen tablets unlikely to increase risk of stroke recurrence

Behavioural therapy as good as medication for OAB symptoms in Parkinson’s disease

Behavioural therapy as good as medication for OAB symptoms in Parkinson’s disease

PM2.5 exposure factors in worsening dementia

PM2.5 exposure factors in worsening dementia

GLP-1RAs look good for idiopathic intracranial hypertension

GLP-1RAs look good for idiopathic intracranial hypertension

Hydrogen–oxygen therapy alleviates sleep disorders and improves mood

Hydrogen–oxygen therapy alleviates sleep disorders and improves mood

Increased risk of stroke in possible sarcopenia patients with fall history

Increased risk of stroke in possible sarcopenia patients with fall history

Common blood test predicts which AD patients will have rapid cognitive decline

Common blood test predicts which AD patients will have rapid cognitive decline

Neuropsychiatric AEs resolve after switch to doravirine-based ARV regimens

Neuropsychiatric AEs resolve after switch to doravirine-based ARV regimens